TAGLN and obesity disorder: The phenotypic changes in SMCs observed in vitro—specifically, the loss of the differentiation markers CALPONIN1 and SM22, along with the maintenance of γSMA expression—are similar to those seen in patients with obesity and in HFD-induced mice.